With allergy season in full swing, Dr. Purvi Parikh joins Saturday TODAY to break down why many may be experiencing worse ...

The FDA has expanded the approval of Valtoco (diazepam nasal spray) to include treatment of seizure clusters in patients aged 2 to 5 years.

Here's the lowdown from allergy doctors on how to get relief, from which medicines to use — and how to best use them — to ...

An alternative, nasal spray, formulation has been developed that demonstrates good efficacy, high tolerability and a very fast onset of action. This study assessed the pharmacokinetics and ...

The state’s wildlife agency reported in mid-April that a grizzly bear charged a man searching for shed antlers near Dupuyer. The bear charged at close range, according to a news release from ...

Scientists from Skolkovo Institute of Science and Technology, together with scientists from the University of Graz, Kanzelhöhe Observatory, and Columbia University, have discovered how coronal ...

Manufacturers of impotence pills are facing a new challenge in the form of a nasal spray that acts in just eight minutes. The Aspirair device is similar to an asthma inhaler, and administers ...

Caused by stress, unhealthy sleeping patterns and an anti-social lifestyle, I realised I was shedding more hair than usual, until I found a spray that helped with regrowing it. It's the Philip ...

Post-nasal drip treatments include rinsing your ... Effect of the use of intranasal spray of essential oils in patients with perennial allergic rhinitis: A prospective study.

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

Megan believes people are going to try more cost-effective beauty techniques, including doing their own hair extensions and spray tans. Young women are buying dupes, not just when it comes to ...

AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...